Connection

Pål Aukrust to Inflammation Mediators

Back to Details
This is a "connection" page, showing publications Pål Aukrust has written about Inflammation Mediators.
Pål Aukrust
Connection Strength
0.481
Inflammation Mediators
  1. NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation-Potential Influence on the Myocardium. J Cardiovasc Pharmacol. 2019 10; 74(4):276-284.
    View in: PubMed
    Score: 0.350
  2. Effect of perfusion temperature on the inflammatory response during pediatric cardiac surgery. Ann Thorac Surg. 2008 Feb; 85(2):611-7.
    View in: PubMed
    Score: 0.039
  3. Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients. Circ Heart Fail. 2018 09; 11(9):e004050.
    View in: PubMed
    Score: 0.020
  4. Interleukin-22 reverses human islet dysfunction and apoptosis triggered by hyperglycemia and LIGHT. J Mol Endocrinol. 2018 04; 60(3):171-183.
    View in: PubMed
    Score: 0.019
  5. CXC chemokine ligand 16 is increased in gestational diabetes mellitus and preeclampsia and associated with lipoproteins in gestational diabetes mellitus at 5 years follow-up. Diab Vasc Dis Res. 2017 11; 14(6):525-533.
    View in: PubMed
    Score: 0.019
  6. Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation. J Immunol. 2017 10 15; 199(8):2910-2920.
    View in: PubMed
    Score: 0.019
  7. Lung disease, T-cells and inflammation in common variable immunodeficiency disorders. Scand J Clin Lab Invest. 2013 Sep; 73(6):514-22.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.